CHMP publishes highlights of its June meeting

The Committee for Medicinal Products for Human Use (CHMP) has published the highlights of its most recent meeting held on 19-22 June.

Eight medicines were recommended for approval by the committee, including two medicine for the treatment of chronic hepatitis C virus reviewed under the EU’s accelerated assessment mechanism.

No negative opinions has been issued, but requests for re-examination of the negative opinions adopted at the May 2017 meeting have been received for three medicines.

Click here to see the summary of recommendations with a full list of approvals, opinions and withdrawals.